Latest West Pharmaceutical Services News & Updates

See the latest news and media coverage for West. We track all announcements, press releases, and industry mentions in real time, all in one place.

West Pharmaceutical Services (West)

Provider of injectable drug packaging, delivery, and contract manufacturing solutions

westpharma.com

Headquarters: Exton, United States
Founded year: 1923
Company type: Public company
Number of employees: 6,400–10,000
Industry: Medical Equipment, Supplies & Distribution

Last updated October 29

Latest news about West Pharmaceutical Services (West)

In short: West raised full-year 2026 guidance after strong Q3 results and lifted dividend 18%.

Company announcements

October 29 West

West reports third-quarter 2026 results raising full-year guidance

Net sales of $874.5 million rose 8.7%. Diluted EPS increased to $3.02. The company raised full-year guidance and announced an 18% dividend increase.

October 19 West

West declares $0.26 quarterly dividend

The company increased the dividend by 18% for the thirty-fourth consecutive annual increase, payable November 18.

October 8 West

West schedules third quarter 2026 conference call

West reports Q3 financials before market open on Oct 29 and hosts a call at 8 AM ET with live webcast access.

August 31 West

West welcomes Michel Lagarde as its new chief executive officer

He will lead strategic initiatives focused on developing innovative treatments and enhancing patient outcomes across global markets.

Media coverage

October 28 RTTNews

West Pharmaceutical Services Inc. Q3 Income Rises

West Pharmaceutical Services Inc. ( WST) released a profit for its third quarter that Increases, from last year The company's earnings came in at $214.0...

October 19 RTTNews

West Pharmaceutical Services Raises Annual Outlook- Update

West Pharmaceutical Services, Inc. , a manufacturer of packaging and delivery systems for injectable drugs, Thursday raised its full-year outlook after reporting improved third-qu...

October 15 Kalkine Media

What Do West Pharmaceutical Services' Latest Results Reveal About This S&P 500 Stock (NYSE:WST)?

West Pharmaceutical Services (NYSE:WST) grew revenue and margins on high-value products and raised its outlook.

September 10 FXEmpire

West Pharmaceutical Services, Inc.

For Q2 2026, West Pharmaceutical Services, Inc. reported EPS of $2.37, beating estimates by 12.77%, and revenue of $872.30M, 2.99% above expectations.

Never miss news about West

Track West and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

West competitors & trending companies

Browse news for competitors to West and other trending companies.